Back
VNET Group- ADR Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
68
VNET
VNET Group- ADR
Last Price:
$7.96
Seasonality Move:
11.33%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$20.30
Seasonality Move:
8.12%
Buy
68
VNET Group- ADR (VNET)
is a Buy
Is VNET Group- ADR a Buy, Sell or Hold?
-
The current VNET Group- ADR [VNET] share price is $8.01. The Score for VNET is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
VNET is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $20.40. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VNET Stock Price Chart
What is VNET Group- ADR's stock price today?
-
The VNET Group- ADR share price today is $8.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNET is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $20.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
VNET Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.09 | Buy |
Relative Strength Index (14 RSI): | 52.47 | Buy |
Chaikin Money Flow: | -1297013 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.71 - 8.63) | Sell |
Bollinger Bands (100): | (5.58 - 8.02) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.95 | Buy |
Relative Strength Index (14 RSI): | 57.41 | Buy |
Chaikin Money Flow: | 8584996 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.15 - 19.17) | Buy |
Bollinger Bands (100): | (17.93 - 55.55) | Sell |
VNET Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.95 | Buy |
20-day SMA: | 8.18 | Sell |
50-day SMA: | 7.2 | Buy |
200-day SMA: | 6.65 | Buy |
8-day EMA: | 7.57 | Buy |
20-day EMA: | 5.57 | Buy |
50-day EMA: | 3.04 | Buy |
200-day EMA: | 0.9 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.93 | Buy |
20-day SMA: | 16.17 | Buy |
50-day SMA: | 21.34 | Sell |
200-day SMA: | 76.43 | Sell |
8-day EMA: | 17.44 | Buy |
20-day EMA: | 12.42 | Buy |
50-day EMA: | 6.68 | Buy |
200-day EMA: | 1.97 | Buy |
VNET Group- ADR Earnings Growth & VNET Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.30 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.52 per share, an increase next quarter of $1.45 per share, a decrease this year of $5.64 per share, and an increase next year of $5.00 per share.
VNET Group- ADR Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |